TLR7 and infection: Ten doses of the TLR-7 agonist GS-986 were given by orogastric (o.g.)administration at 0.3 mg/kg biweekly at 40, 42, 44, 46, 48, 52, 54, 56, 58, and 60 weeks post infection (orange arrows in Fig 1A).